CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Ed Wirth, MD, PhD, InVivo’s Chief Science Officer, is scheduled to present at the Clinical Outlooks for Regenerative Medicine Conference on Tuesday, June 19, 2012. Dr. Wirth will speak on the “Neurodegenerative Disease and Spinal Cord Injury Panel” at 1:30 pm. The conference, organized jointly by the Alliance for Regenerative Medicine and the Harvard Stem Cell Institute, will be held at the Starr Center in the Schepens Eye Research Institute in Boston, MA.
